Fig. 3From: Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancerCTC detection whole blood in PDAC cases. a. Frequency of CTC in peripheral blood in PDAC. b. AsPc-1 and PaTu8988S detection in spiked peripheral blood (100 cells/ml) using the CellSearch® system. c. Kaplan Meier survival analysis of CTC status in peripheral bloodBack to article page